R&D Partner Content 3rd Process Development for Cell Therapies Summit In the dynamic cell therapy landscape, where financial challenges continue to prevail, the emphasis on innovative process development becomes pivotal.
R&D Partner Content GLP-1-Based Therapeutics Summit Advancing Specialized, Durable, & Efficacious GLP-1s & Investigating Commercial Opportunity to Crystallize Pipeline Strategy & Indication Expansion
R&D Partner Content Cell & Gene Therapy Pricing & Reimbursement Summit Unlocking Patient Access to Affordable Advanced Therapies
R&D Partner Content 6th Allogeneic Cell Therapies Summit Driving Potency, Efficacy & Durability of Universal Cell Therapies
R&D Partner Content The 3rd Next-Generation Conjugates Summit is back! Driving Innovation and Pioneering Novel Payload & Format Conjugate Design
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.